Carboxymethyl β-glucan binds to corneal epithelial cells and increases cell adhesion to laminin and resistance to oxidative stress

Cornea

Volumn 26, Issue 1, 2007, Pages 73-79

  Porcu, Marco ^a   Guarna, Francesco ^a   Formentini, Laura ^a   Faraco, Giuseppe ^a   Fossati, Silvia ^a   Mencucci, Rita ^a   Rapizzi, Emilio ^a   Menchini, Ugo ^a   Moroni, Flavio ^a   Chiarugi, Alberto ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Adhesion; Cornea; Glucan; Laminin; Oxidative stress

Indexed keywords

BETA GLUCAN; CARBOXYMETHYL BETA GLUCAN; POLYSACCHARIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL ADHESION; CELL DEATH; CELL LABELING; CELL PROLIFERATION; CELL PROTECTION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORNEA EPITHELIUM; DIGITAL IMAGING; IMAGE ANALYSIS; IMAGE RECONSTRUCTION; MICROSCOPY; NOCICEPTIVE STIMULATION; NONHUMAN; OXIDATIVE STRESS; PHOTOTOXICITY; PRIORITY JOURNAL; RABBIT; ULTRAVIOLET B RADIATION;

ANIMALS; BETA-GLUCANS; CELL ADHESION; CELL MEMBRANE; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; EPITHELIUM, CORNEAL; FLUORESCENT DYES; HYDROGEN PEROXIDE; LAMININ; OXIDATIVE STRESS; RABBITS; SACCHAROMYCES CEREVISIAE;

EID: 33846030480     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICO.0b013e31802e3872     Document Type: Article

References (35)

1. Babayigit H, Kucuk C, Sozuer E, et al. Protective effect of beta-glucan on lung injury after cecal ligation and puncture in rats. Intensive Care Med. 2005;31:865-870.
2. Breivik T, Opstad PK, Engstad R, et al. Soluble beta-1,3/1,6-glucan from yeast inhibits experimental periodontal disease in Wistar rats. J Clin Periodontol. 2005;32:347-352.
3. Kayali H, Ozdag MF, Kahraman S, et al. The antioxidant effect of beta-glucan on oxidative stress status in experimental spinal cord injury in rats. Neurosurg Rev. 2005;28:298-302.
4. Kirmaz C, Bayrak P, Yilmaz O, et al. Effects of glucan treatment on the Th1/Th2 balance in patients with allergic rhinitis: a double-blind placebo-controlled study. Eur Cytokine Netw. 2005;16:128-134.
5. Lyuksutova OI, Murphey ED, Toliver-Kinsky TE, et al. Glucan phosphate treatment attenuates burn-induced inflammation and improves resistance to Pseudomonas aeruginosa burn wound infection. Shock. 2005;23:224-232.
6. Modak S, Koehne G, Vickers A, et al. Rituximab therapy of lymphoma is enhanced by orally administered (1→3),(1→4)-D-beta-glucan. Leuk Res. 2005;29:679-683.
7. Sener G, Toklu H, Ercan F, et al. Protective effect of beta-glucan against oxidative organ injury in a rat model of sepsis. Int Immunopharmacol. 2005;5:1387-1396.
8. Yan J, Allendorf DJ, Brandley B. Yeast whole glucan particle (WGP) beta-glucan in conjunction with antitumour monoclonal antibodies to treat cancer. Expert Opin Biol Ther. 2005;5:691-702.
9. Zulli F, Applegate LA, Frenk E, et al. Photoprotective effects of CM-glucan on cultured human skin cells. Euro Cosmetics. 1985;95:46-50.
10. Brown GD, Gordon S. Immune recognition of fungal beta-glucans. Cell Microbiol. 2005;7:471-479.
11. Sandula J, Machova E, Hribalova V. Mitogenic activity of particulate yeast beta-(1→3)-D-glucan and its water-soluble derivatives. Int J Biol Macromol. 1995;17:323-326.
12. Leibovich SJ, Danon D. Promotion of wound repair in mice by application of glucan. J Reticuloendothel Soc. 1980;27:1-11.
13. Kogan G, Sandula J, Korolenko TA, et al. Increased efficiency of Lewis lung carcinoma chemotherapy with a macrophage stimulator-yeast carboxymethyl glucan. Int Immunopharmacol. 2002;2:775-781.
14. Cejkova J, Stipek S, Crkovska J, et al. UV Rays, the prooxidant/ antioxidant imbalance in the cornea and oxidative eye damage. Physiol Res. 2004;53:1-10.
15. Dick B, Schwenn O, Pfeiffer N. Classification of visco-elastic substances for ophthalmologic surgery. Ophthalmologe. 1999;96:193-211.
16. Lane SS, Lindstrom RL. Viscoelastic agents: formulation, clinical applications, and complications. Semin Ophthalmol. 1992;7:253-260.
17. Zulli F, Suter F, Blitz H, et al. Carboxymethylated b-(1-3)-glucan. Cosmetics and Toiletries. 1996;111:91-96.
18. Carrington WA, Lynch RM, Moore ED, et al. Superresolution three-dimensional images of fluorescence in cells with minimal light exposure. Science. 1995;268:1483-1487.
19. Babincova M, Bacova Z, Machova E, et al. Antioxidant properties of carboxymethyl glucan: comparative analysis. J Med Food. 2002;5:79-83.
20. Slamenova D, Labaj J, Krizkova L, et al. Protective effects of fungal (1→3)-beta-D-glucan derivatives against oxidative DNA lesions in V79 hamster lung cells. Cancer Lett. 2003;198:153-160.
21. Ciuffi M, Pisanello M, Pagliai G, et al. Antioxidant protection in cultured corneal cells and whole corneas submitted to UV-B exposure. J Photochem Photobiol B. 2003;71:59-68.
22. Tzianabos AO, Cisneros RL. Prophylaxis with the immunomodulator PGG glucan enhances antibiotic efficacy in rats infected with antibiotic-resistant bacteria. Ann N Y Acad Sci. 1996;797:285-287.
23. Liang J, Melican D, Cafro L, et al. Enhanced clearance of a multiple antibiotic resistant Staphylococcus aureus in rats treated with PGG-glucan is associated with increased leukocyte counts and increased neutrophil oxidative burst activity. Int J Immunopharmacol. 1998;20:595-614.
24. Patchen ML, Vaudrain T, Correira H, et al. In vitro and in vivo hematopoietic activities of Betafectin PGG-glucan. Exp Hematol. 1998;26:1247-1254.
25. Czop JK, Austen KF. A beta-glucan inhibitable receptor on human monocytes: its identity with the phagocytic receptor for particulate activators of the alternative complement pathway. J Immunol. 1985;134:2588-2593.
26. Janusz MJ, Austen KF, Czop JK. Isolation of a yeast heptaglucoside that inhibits monocyte phagocytosis of zymosan particles. J Immunol. 1989;142:959-965.
27. Wakshull E, Brunke-Reese D, Lindermuth J, et al. PGG-glucan, a soluble beta-(1,3)-glucan, enhances the oxidative burst response, microbicidal activity, and activates an NF-kappa B-like factor in human PMN: evidence for a glycosphingolipid beta-(1,3)-glucan receptor. Immunopharmacology. 1999;41:89-107.
28. Brown GD, Gordon S. Immune recognition. A new receptor for beta-glucans. Nature. 2001;413:36-37.
29. Heinsbroek SE, Brown GD, Gordon S. Dectin-1 escape by fungal dimorphism. Trends Immunol. 2005;26:352-354.
30. Kougias P,Wei D, Rice PJ, et al. Normal human fibroblasts express pattern recognition receptors for fungal (1→3)-beta-D-glucans. Infect Immun. 2001;69:3933-3938.
31. Masur SK, Cheung JK, Antohi S. Identification of integrins in cultured corneal fibroblasts and in isolated keratocytes. Invest Ophthalmol Vis Sci. 1993;34:2690-2698.
32. Nakamura M, Nishida T. Synergistic effects of hyaluronan and fibronectin on epithelial migration in rabbit cornea in vitro. Cornea. 1999;18:686-692.
33. Friedl P. Prespecification and plasticity: shifting mechanisms of cell migration. Curr Opin Cell Biol. 2004;16:14-23.
34. Burgalassi S, Raimondi L, Pirisino R, et al. Effect of xyloglucan (tamarind seed polysaccharide) on conjunctival cell adhesion to laminin and on corneal epithelium wound healing. Eur J Ophthalmol. 2000;10:71-76.
35. Krizkova L, Durackova Z, Sandula J, et al. Fungal beta-(1-3)-D-glucan derivatives exhibit high antioxidative and antimutagenic activity in vitro. Anticancer Res. 2003;23:2751-2756.